USPTO serial 79142345
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen White Zelano and Branigan, PC2200 Clarendon Blvd Suite 1400Arlington, VA 22201UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Creation, compilation, management of databases and central data files in the field of medicine and clinical trials Database management, collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics; compilation and systematization of data into a central file; public relations; business information, namely, provision of commercial information in the fields of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials | SECTION 71 - CANCELLED | — |
| 041 | Training services in the field of medicine and clinical trials; publishing writing and publication of books and texts other than advertising texts; non-downloadable electronic publication of texts in the nature of articles, magazines, brochures in the field of online medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions, seminars in the field of medicine; teaching in the field of medicine and clinical trials | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research and development; scientific research for medical purposes in the field of medicine and clinical trials; Scientific and clinical research studies in the fields of medicine, the prevention, treatment and management of illness, health care delivery; chemical and biological analysis, research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemical, biological and pharmaceutical products; software design and development; scientific laboratory services; research on chemical reagents for medical use, namely, biomarkers | SECTION 71 - CANCELLED | — |
| 044 | Medical services; pharmacy advice; Providing information about the diagnosis and treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, and awareness and information regarding the treatment regarding the aforementioned diseases and illnesses | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 31, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Mar 31, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Mar 31, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 8, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 7, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 7, 2022 | INPC | INVALIDATION PROCESSED | — |
| Mar 16, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 16, 2021 | C71T | CANCELLED SECTION 71 | — |
| Dec 30, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 7, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 8, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 26, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 8, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 1, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 1, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 30, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 30, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 24, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 14, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 14, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 8, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 24, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 10, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 10, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 10, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 3, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2014 | ALIE | ASSIGNED TO LIE | — |
| Aug 25, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 14, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 25, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 25, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 25, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 25, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 24, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 21, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 19, 2014 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Feb 17, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |